Exchange: NYSE
Industry: Drugs Wholesale
Last Trade: 4:02 PM ET 2/9/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.07 | 0.91 | 17.58 |
| EPS, GAAP | 0.90 | 0.85 | 5.88 |
| Consensus Estimate | 1.05 | 0.88 | 19.32 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.88 | 3.40 | 14.12 |
| EPS, GAAP | 3.43 | 2.99 | 14.72 |
| Consensus Estimate | 3.81 | NA | NA |
| MHS | Industry Average | |
| P/E (TTM) | 17.64 | 19.10 |
| P/E (Forward) | 13.35 | 16.30 |
| PEG Ratio | 1.04 | 1.35 |
| Price/Sales | 0.35 | 0.20 |
| Beta | 0.71 | 0.97 |
| 1:01 PM | 2/8/2012 | Insurer Coventry Health Care Extends Pact With Medco By 3 Years |
| 2:14 PM | 2/6/2012 | Big Grocery Chains Ask FTC To Block Medco-Express Scripts Deal -Reuters |
| 2/9/2012 | FTC Decision On Medco-Express Scripts Deal Isn't Imminent (WSJ.com) |
| 1/27/2012 | Express Scripts' Lipitor Move Shows Pressure on Pfizer (WSJ.com) |
| 1/27/2012 | FTC Sues To Block Omicare/PharMerica Merger; Express/Medco Next? (OCR, PMC, MHS, ESRX, T) (24/7 Wall St) |
| 1/19/2012 | This Drug Middleman Is No Middling Stock (Barrons.com) |
| 1/19/2012 | Risks Abound In Express Scripts & Medco Merger (MHS, ESRX, T, CHSI, MNA) (24/7 Wall St) |
| 1/18/2012 | Express Scripts Has Healthy Upside (Barrons.com) |
| 1/17/2012 | Listen Up, Class: Here's How to Profit (Barrons.com) |
| 1/12/2012 | CVS Settles Deceptive Pricing Charges (WSJ.com) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
